메뉴 건너뛰기




Volumn 31, Issue 2-3, 2001, Pages 277-284

Activity and toxicity of gemcitabine and gemcitabine+vinorelbine in advanced non-small-cell lung cancer elderly patients: Phase II data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trial

Author keywords

Chemotherapy; Elderly; Gemcitabine; NSCLC; Randomised phase II study; Vinorelbine

Indexed keywords

GEMCITABINE; NAVELBINE;

EID: 0035143238     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(00)00194-X     Document Type: Article
Times cited : (128)

References (14)
  • 1
    • 0028843552 scopus 로고
    • Chemotherapy in non small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised trials
    • (1995) Br. Med. J. , vol.311 , pp. 899-909
  • 5
    • 0031105526 scopus 로고    scopus 로고
    • Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non small cell lung cancer. A two-stage phase II study
    • (1997) Eur. J. Cancer , vol.33 , pp. 392-397
    • Gridelli, C.1    Perrone, F.2    Gallo, C.3
  • 6
    • 0006453669 scopus 로고    scopus 로고
    • Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer
    • (1999) J. Natl. Cancer Inst. , vol.91 , pp. 66-72
  • 10
    • 0006267504 scopus 로고    scopus 로고
    • The GemVin Investigators, Gridelli C, Frontini L, Perrone F et al. Gemcitabine plus Vinorelbine in advanced non-small cell lung cancer. A phase II study of three different doses. Br J Cancer 2000;83:707-14.
  • 11
    • 0344980098 scopus 로고    scopus 로고
    • Gemcitabine plus vinorelbine in non small cell lung carcinoma patients age 70 years or older or patients who cannot receive cisplatin
    • (1999) Cancer , vol.86 , pp. 1463-1469
    • Feliu, J.1    Lopez Gomez, L.2    Madronal, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.